Skip to content

Pacira BioSciences, Inc. PCRX Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
AtriCure logo
AtriCureATRC

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s common stock, shares issued (in shares)?
Pacira BioSciences, Inc. (PCRX) reported common stock, shares issued (in shares) of $48.33M in Q1 2026.
How has Pacira BioSciences, Inc.'s common stock, shares issued (in shares) changed year-over-year?
Pacira BioSciences, Inc.'s common stock, shares issued (in shares) increased by 2.6% year-over-year, from $47.12M to $48.33M.
What is the long-term trend for Pacira BioSciences, Inc.'s common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock, shares issued (in shares) has grown at a 1.9% compound annual growth rate (CAGR), from $43.64M to $47.89M.